Training program for future drug developers
Molecular Pharmacology Training Program
['FUNDING_TRAINING'] · STANFORD UNIVERSITY · NIH-10837775
This program at Stanford is designed to help students learn how to create and develop new medicines, giving them both classroom knowledge and real-world experience in labs and clinics, so they can become skilled scientists who can tackle today's health challenges.
Quick facts
| Phase | ['FUNDING_TRAINING'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | STANFORD UNIVERSITY (nih funded) |
| Locations | 1 site (STANFORD, UNITED STATES) |
| Trial ID | NIH-10837775 on ClinicalTrials.gov |
What this research studies
The Stanford Molecular Pharmacology Training Program (MPTP) focuses on equipping predoctoral students with the skills necessary for drug discovery and development. This program combines rigorous academic coursework with hands-on experiences, including internships in biotech and clinical settings. Trainees engage in independent research while learning from experts in various fields related to therapeutic development. The program aims to bridge the gap between basic science and clinical application, fostering a new generation of scientists capable of addressing current therapeutic needs.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research are predoctoral students in the biosciences interested in drug development.
Not a fit: Patients who are not in academia or do not have an interest in pursuing a career in drug discovery may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of more effective therapeutics that better meet clinical needs.
How similar studies have performed: Similar training programs have shown success in producing skilled professionals who contribute to advancements in drug development.
Where this research is happening
STANFORD, UNITED STATES
- STANFORD UNIVERSITY — STANFORD, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: CHEN, JAMES K — STANFORD UNIVERSITY
- Study coordinator: CHEN, JAMES K
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.